EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma

Shiv K Gupta iD, Sonia Jain, Teddy R Friedman, Jann N Sarkaria iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27146517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shiv K Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Temozolomide, Glioblastoma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Mayo Clinic, and the National Cancer Institute, Eagles 5th District Cancer Telethon- Cancer Research Fund, the Midwest RadOnc Clinical Innovations Award, and the Center of Innovation for Brain Tumor Therapeu….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ) remains the cornerstone of chemotherapeutic agent for glioblastoma (GBM), yet intrinsic and acquired resistance severely limits its clinical benefit. While O6-methylguanine-DNA methyltransferase (MGMT)–mediated repair of TMZ-induced O6-methylguanine (O6-meG) lesions has been extensively studied, the DNA mismatch repair (MMR) pathway is increasingly recognized as a key determinant of TMZ cytotoxicity. Canonical MMR, mediated by MutSα (MSH2–MSH6) and MutLα (MLH1–PMS2) complexes, recognizes O6-meG: thymine mispairs generated during replication and initiates futile repair cycles that culminate in replication stress, replication fork collapse, and apoptotic signaling; intact canonical MMR is, therefore, required for TMZ-induced cell death. Disruption of canonical MMR, frequently via acquired MSH6 mutations, confers TMZ tolerance and drives hypermutated recurrent GBM. Beyond mismatch correction, MMR proteins perform non-canonical functions in DNA damage signaling, replication stress responses, transcriptional regulation, chromatin dynamics, and immune modulation. These activities may shift the outcome from cytotoxic futile repair toward replication stress adaptation, Translesion synthesis (TLS)-mediated lesion tolerance, immune remodeling, and therapeutic resistance. Notably, partial attenuation or functional diversion of MMR may decouple lesion recognition from cytotoxic signaling, enabling TLS-mediated lesion tolerance without complete loss of MMR activity. This review integrates current insights into canonical and non-canonical MMR functions in GBM, defines their distinct contributions to TMZ sensitivity and resistance, and highlights therapeutic opportunities to exploit MMR-associated dependencies, including synthetic lethal strategies and immunotherapeutic vulnerabilities linked to MMR deficiency-driven hypermutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Mismatch RepairTemozolomideGlioblastomaDrug Resistance, NeoplasmAntineoplastic Agents, AlkylatingBrain NeoplasmsHumansAnimals

Stichwörter der Autor:innen

DNA damage responseMGMT promoter methylationMSH6genomic instabilityhypermutationreplication stresssynthetic lethalitytranslesion synthesis

Substanzen

TemozolomideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.

ORCID-Profile: Shiv K Gupta, Jann N Sarkaria

Förderung

  • NCI NIH HHS
  • Mayo Clinic, and the National Cancer Institute
  • Eagles 5th District Cancer Telethon- Cancer Research Fund, the Midwest RadOnc Clinical Innovations Award, and the Center of Innovation for Brain Tumor Therapeu…

Zitieren

APA

Gupta, S. K., Jain, S., Friedman, T. R., & Sarkaria, J. N. (2026). Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146517

Vancouver

Gupta SK, Jain S, Friedman TR, Sarkaria JN. Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146517

BibTeX
@article{Gupta2026,
  author = {Gupta, Shiv K and Jain, Sonia and Friedman, Teddy R and Sarkaria, Jann N},
  title = {Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27146517}
}
Kostenlos starten →